Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof

Details for Australian Patent Application No. 2011207289 (hide)

Owner Acetylon Pharmaceuticals Inc.

Inventors Van Duzer, John H.; Mazitschek, Ralph; Ogier, Walter; Bradner, James Elliott; Huang, Guoxiang; Xie, Dejian; Yu, Nan

Agent Davies Collison Cave

Pub. Number AU-A-2011207289

PCT Pub. Number WO2011/091213

Priority 61/336,460 22.01.10 US

Filing date 21 January 2011

Wipo publication date 28 July 2011

International Classifications

C07C 233/78 Carboxylic acid amides

A61K 31/505 - Pyrimidines

A61P 25/00 Drugs for disorders of the nervous system

A61P 35/00 Antineoplastic agents

C07D 239/42 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

16 August 2012 PCT application entered the National Phase

  PCT publication WO2011/091213 Priority application(s): WO2011/091213

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011207294-System and method for correcting data for deformations during image-guided procedures

2011207281-Intracameral sustained release therapeutic agent implants